Docoh
Loading...

GOVX Geovax Labs

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and cancer using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G. Hildebrand on September 9, 2006 and is headquartered in Smyrna, GA.

Company profile

Ticker
GOVX, GOVXW
Exchange
Website
CEO
David Dodd
Employees
Incorporated
Location
Fiscal year end
Former names
DAUPHIN TECHNOLOGY INC
SEC CIK
IRS number
870455038

GOVX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

6 May 21
21 Jun 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Geovax Labs earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 20.84M 20.84M 20.84M 20.84M 20.84M 20.84M
Cash burn (monthly) (positive/no burn) (positive/no burn) 521.36K 315.47K 540.34K 334.41K
Cash used (since last report) n/a n/a 1.41M 850.76K 1.46M 901.87K
Cash remaining n/a n/a 19.44M 19.99M 19.39M 19.94M
Runway (months of cash) n/a n/a 37.3 63.4 35.9 59.6

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
29 Sep 20 Randal D Chase Common Stock Buy Aquire P No No 5 16,613 83.07K 16,613
29 Sep 20 Randal D Chase Common Stock Purchase Warrant Common Stock Buy Aquire P No No 5 16,613 83.07K 16,613
29 Sep 20 Dean G Kollintzas Common Stock Buy Aquire P No No 5 11,987 59.94K 11,987
29 Sep 20 Dean G Kollintzas Common Stock Purchase Warrant Common Stock Buy Aquire P No No 5 11,987 59.94K 11,987
29 Sep 20 Spencer John N JR Common Stock Buy Aquire P No No 5 21,024 105.12K 21,024
29 Sep 20 Spencer John N JR Common Stock Purchase Warrant Common Stock Buy Aquire P No No 5 21,024 105.12K 21,024
29 Sep 20 Robert T Mcnally Common Stock Buy Aquire P No No 5 53,925 269.63K 53,925
29 Sep 20 Robert T Mcnally Common Stock Purchase Warrant Common Stock Buy Aquire P No No 5 53,925 269.63K 53,925
29 Sep 20 Mark Reynolds Common Stock Buy Aquire P No No 5 60,184 300.92K 60,184
29 Sep 20 Mark Reynolds Common Stock Purchase Warrant Common Stock Buy Aquire P No No 5 60,184 300.92K 60,184

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

10.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 12 2 +500.0%
Opened positions 11 1 +1000.0%
Closed positions 1 4 -75.0%
Increased positions 0 0
Reduced positions 0 1 EXIT
13F shares
Current Prev Q Change
Total value 2.74M 1.79M +53.6%
Total shares 650.09K 528.39K +23.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Cavalry Fund I Management 219.34K $1.01M NEW
Bigger Capital Fund L P 151.12K $511K 0.0%
Citadel Advisors 75.3K $330K NEW
VIRT Virtu Financial 60.49K $265K NEW
Vanguard 50.55K $221K NEW
Geode Capital Management 37.52K $164K NEW
Welch & Forbes 27.99K $123K NEW
WFC Wells Fargo & Co. 10.54K $46K NEW
Squarepoint Ops 10.53K $46K NEW
BAC Bank Of America 2.77K $12K NEW
Largest transactions
Shares Bought/sold Change
Sabby Management 0 -377.27K EXIT
Cavalry Fund I Management 219.34K +219.34K NEW
Citadel Advisors 75.3K +75.3K NEW
VIRT Virtu Financial 60.49K +60.49K NEW
Vanguard 50.55K +50.55K NEW
Geode Capital Management 37.52K +37.52K NEW
Welch & Forbes 27.99K +27.99K NEW
WFC Wells Fargo & Co. 10.54K +10.54K NEW
Squarepoint Ops 10.53K +10.53K NEW
BAC Bank Of America 2.77K +2.77K NEW
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Australia, began, bought, checkpoint, clade, compelling, concept, constructed, currency, deal, Europe, expend, experimental, external, franchise, GOVX, IRS, Japan, light, move, objective, opportunity, recombinant, relevant, stimulating, subtype, Symbol, target, targeted, Title, variance, Western
Removed: account, advancing, applicable, authorized, cancellation, certificate, Commencing, connection, conserve, consisted, consummated, continuing, delayed, Designation, dilute, dividend, doubt, effected, entitled, equal, event, expertise, fiscal, history, holder, incorporation, increased, independent, investing, involving, joint, liquidation, lower, medical, November, order, payment, penalty, pertinent, potentially, predominantly, preference, receipt, reduced, reimburse, represent, requiring, secure, sell, split, stated, statement, summary, volume, voting